Yılmaz Kayhan, Özsoy Çağatay, Ölçücü Mahmut Taha, Aksaray Eren Erdi, Okuducu Yahya, Ateş Mutlu
Department of Urology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
Turk J Urol. 2021 Mar;47(2):125-130. doi: 10.5152/tud.2020.20411. Epub 2020 Nov 20.
In this study, we aimed to present the perioperative and postoperative outcomes and early continence rates of the first 50 patients who underwent Retzius-sparing robot-assisted laparoscopic radical prostatectomy (RS-RALP) in our clinic for prostate adenocarcinoma.
Between December 2018 and December 2019, 50 patients who underwent RS-RALP by 2 surgeons in our clinic were enrolled in the study. Preoperative, perioperative, and postoperative clinical data were analyzed retrospectively. Procedure-specific complications were graded according to the Clavien-Dindo classification. The continence status of the patients was recorded in the 1 week, 1 month, and 3 month after catheter removal. Zero pads or 1 safety pad per day was accepted as total continence.
The mean age of the patients was 66.6 (57-75) years. According to the D'Amico classification, 36% of patients were at low risk, 48% at intermediate risk, and 16% at high risk. Bilateral or unilateral nerve-sparing procedure was performed in 76% of the patients. There were no intraoperative complications. A total of 9 (18%) patients had a postoperative complication (7 with grade 1, 1 with grade 2, and 1 with grade 3 complications). Whereas 32% of the patients had an extraprostatic extension, 22% had seminal vesicle invasion. The overall positive surgical margin rate was 26%. At 1 week, 1 month, and 3 months after surgery, 64%, 80%, and 92% of men who underwent RS-RALP were continent, respectively.
Our study showed that this new surgical technique can be a safe and feasible method because high rates of early continence were achieved in the patients who underwent RS-RALP without increasing the risk of complications.
在本研究中,我们旨在呈现我院首批50例因前列腺腺癌接受保留Retzius间隙机器人辅助腹腔镜根治性前列腺切除术(RS-RALP)患者的围手术期和术后结局以及早期控尿率。
2018年12月至2019年12月期间,我院2名外科医生为50例患者实施了RS-RALP,并将其纳入本研究。对术前、围手术期和术后临床数据进行回顾性分析。根据Clavien-Dindo分类法对特定手术并发症进行分级。在拔除导尿管后的第1周、1个月和3个月记录患者的控尿状态。每天使用零片或1片安全护垫被视为完全控尿。
患者的平均年龄为66.6(57 - 75)岁。根据D'Amico分类,36%的患者为低风险,48%为中风险,16%为高风险。76%的患者进行了双侧或单侧神经保留手术。术中无并发症发生。共有9例(18%)患者出现术后并发症(7例为1级,1例为2级,1例为3级并发症)。32%的患者有前列腺外侵犯,22%有精囊侵犯。总体手术切缘阳性率为26%。在接受RS-RALP手术的男性患者中,术后1周、1个月和3个月时的控尿率分别为64%、80%和92%。
我们的研究表明,这种新的手术技术可以是一种安全可行的方法,因为接受RS-RALP手术的患者早期控尿率高,且未增加并发症风险。